Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Getting a fresh look at Ocular's axitinib ahead of its wet amd phase 3 data readout

Ticker(s): OCUL

Who's the expert?

Institution: Dallas Retina

Vitreoretinal surgeon at Dallas Retina, specializing in retinal detachment repair, macular disorders, diabetic retinopathy, retinal vein occlusions, and age-related macular degeneration.
Serves as President of the American Retina Forum, leading advancements in vitreoretinal care and education for the national community.
Conducts research on complex vitreoretinal surgical techniques and outcomes, contributing to innovations in retinal disease management and patient care.

Interview Goal

This call will discuss the current treatment landscape and the potential of axitinib, a hydrogel being developed by Ocular for the treatment of wet AMD, including its currently available data.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.